Tradestie Institutional Equity Comparison Engine
OKYO vs AACBR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OKYO Overall Edge
OKYO Captures Institutional Edge (2โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OKYO Pharma Limited Ordinary Shares (OKYO) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AACBR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AACBR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
OKYO N/M vs AACBR N/M Fwd P/E
Growth & Margin Winner
OKYO
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
OKYO
1Y -47.0% vs -96.7% ยท 52W Pos 3% vs 1%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OKYO
NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap
$62.7M
1M Return
-27.21%
1Y Return
-47.03%
Forward P/E
N/M
Unified AI Score
42.8 / 100
HOLD
Tech 38.0
Fund 54.0
Flow 50.0
Mom 45.0
AACBR
US Equity
AACBR
Institutional Equity
$0.01
+81.82% 1D
Market Cap
N/A
1M Return
-96.67%
1Y Return
-96.67%
Forward P/E
N/M
Unified AI Score
48.2 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OKYO -47.03%
AACBR -96.67%
Spread: +77.16 pp (OKYO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
OKYO TTM Op. Margin: 0.0%
AACBR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs AACBR. Trailing 12-month operating profitability (OKYO 0.0% vs AACBR N/A) and valuation multiples (OKYO N/M vs AACBR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OKYO | AACBR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.7M | N/A | Larger Scale | OKYO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | OKYO |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | OKYO |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | OKYO |
| Return on Equity (ROE) Capital Efficiency | -263.8% | N/A | Higher ROE | OKYO |
| 52-Week Range Position Momentum | 3% ($1โ$3) | 1% ($0โ$1) | Stronger Trend | OKYO |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 76% Vol | -3.40ฮฒ ยท 4548% Vol | Lower Realized Risk | OKYO |
| Unified Institutional Score Composite Signal | 42.8 / 100 (HOLD) | 48.2 / 100 (HOLD) | Higher Composite | AACBR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OKYO vs AACBR Buy Guide
OKYO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AACBR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OKYO nor AACBR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.